---
figid: PMC7418797__CTM2-10-e127-g001
figtitle: Therapeutic mechanism related to natural products
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7418797
filename: CTM2-10-e127-g001.jpg
figlink: pmc/articles/PMC7418797/figure/ctm2127-fig-0001/
number: F1
caption: Therapeutic mechanism related to natural products. The mechanism of action
  of poricoic acids, poricoic acid ZG (PZG), poricoic acid ZH (PZH), poricoic acid
  ZC (PZC), poricoic acid ZD (PZD), and poricoic acid ZE (PZE), which are novel RAS
  inhibitors. The figure shows the interaction between TGF‐β/Smad signaling pathway
  and Wnt/β‐catenin signaling pathway. Among them, natural products selectively inhibit
  the phosphorylation of Smad3 induced by TGF‐β1 by inhibiting RAS and blocking the
  interaction between TGF‐βRI and Smad3. At the same time, it can eventually inhibit
  renal fibrosis by reducing the expression levels of Wnt and β‐catenin proteins
papertitle: TGF‐β/Smad and Wnt/β‐catenin signaling pathways are involved in renal
  fibrosis and its therapies.
reftext: Jialiang Ying, et al. Clin Transl Med. 2020 Jul;10(3):e127.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9645048
figid_alias: PMC7418797__F1
figtype: Figure
redirect_from: /figures/PMC7418797__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7418797__CTM2-10-e127-g001.html
  '@type': Dataset
  description: Therapeutic mechanism related to natural products. The mechanism of
    action of poricoic acids, poricoic acid ZG (PZG), poricoic acid ZH (PZH), poricoic
    acid ZC (PZC), poricoic acid ZD (PZD), and poricoic acid ZE (PZE), which are novel
    RAS inhibitors. The figure shows the interaction between TGF‐β/Smad signaling
    pathway and Wnt/β‐catenin signaling pathway. Among them, natural products selectively
    inhibit the phosphorylation of Smad3 induced by TGF‐β1 by inhibiting RAS and blocking
    the interaction between TGF‐βRI and Smad3. At the same time, it can eventually
    inhibit renal fibrosis by reducing the expression levels of Wnt and β‐catenin
    proteins
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRP5
  - HRAS
  - KRAS
  - NRAS
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - NECTIN1
  - NR1I2
  - ATP6AP2
  - ZFYVE9
  - SAR1A
  - ADAR
  - DVL1P1
  - SMAD2
  - SMAD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - XIRP1
  - SMAD4
  - APC
  - PROC
  - ILK
  - AKT1
  - AKT2
  - AKT3
  - SMAD7
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - CTNNB1
  - SERPINE1
  - S100A4
  - ATL1
  - AIFM2
  - SNAI1
  - MMP7
  - PZG
---
